Inhibition of fatty acid synthase by amentoflavone suppresses HER2/neu (erbB2) oncogene expression in breast cancer cells

被引：0
|
作者：
Chang, E. [1 ,2 ]
Lee, J. [3 ]
Lee, M. [4 ]
Cha, E. [4 ]
Sul, J. [1 ,2 ]
Byun, W. [3 ]
机构：
[1] Chungnam Natl Univ, Sch Med, Dept Surg, Taejon, South Korea
[2] Chungnam Natl Univ, Res Inst Med Sci, Taejon, South Korea
[3] Chungnam Natl Univ Hosp, Dept Surg, Taejon, South Korea
[4] Chungnam Natl Univ Hosp, Reg Canc Inst, Taejon, South Korea
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70442-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [1] Fatty Acid Synthase Inhibition by Amentoflavone Suppresses HER2/neu (erbB2) Oncogene in SKBR3 Human Breast Cancer Cells
    Lee, Jin Sun
    Sul, Ji Young
    Park, Jun Beom
    Lee, Myung Sun
    Cha, Eun Young
    Song, In Sang
    Kim, Je Ryong
    Chang, Eil Sung
    PHYTOTHERAPY RESEARCH, 2013, 27 (05) : 713 - 720
  • [2] Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
    Menendez, JA
    Vellon, L
    Mehmi, I
    Oza, BP
    Ropero, S
    Colomer, R
    Lupu, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (29) : 10715 - 10720
  • [3] ERBB2 (HER2) Testing in Breast Cancer
    Hilal, Talal
    Romond, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (12): : 1280 - 1281
  • [4] Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu)
    Reid, Alison
    Vidal, Laura
    Shaw, Heather
    de Bono, Johann
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) : 481 - 489
  • [5] The erbB2/HER2/neu receptor polymorphism IIe655Val and breast cancer
    Cox, DG
    Hankinson, SE
    Hunter, DJ
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 447 - 450
  • [6] Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer
    Carmen Duran, M.
    Vega, Francisco
    Moreno-Bueno, Gema
    Jesus Artiga, M.
    Sanchez, Lydia
    Palacios, Jose
    Ridley, Anne
    Timms, John F.
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (09) : 1313 - 1326
  • [7] Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
    Moutafi, Myrto
    Robbins, Charles J.
    Yaghoobi, Vesal
    Fernandez, Aileen, I
    Martinez-Morilla, Sandra
    Xirou, Vasiliki
    Bai, Yalai
    Song, Yan
    Gaule, Patricia
    Krueger, Joseph
    Bloom, Kenneth
    Hill, Salisha
    Liebler, Daniel C.
    Fulton, Regan
    Rimm, David L.
    LABORATORY INVESTIGATION, 2022, 102 (10) : 1101 - 1108
  • [8] EXPRESSION OF THE HER-2/NEU/C-ERBB-2 ONCOGENE IN BREAST-CANCER
    PRESS, MF
    GODOLPHIN, W
    SLAMON, DJ
    LABORATORY INVESTIGATION, 1989, 60 (01) : A73 - A73
  • [9] Treatment options in ErbB2 (HER2)-overexpressing breast cancer
    Jackisch, Christian
    BREAST CARE, 2008, 3 : 1 - 1
  • [10] Challenges in the treatment of ErbB2 (HER2)-positiive breast cancer
    Jackisch, Christian
    EJC SUPPLEMENTS, 2008, 6 (05): : 7 - 14
12345